Nitto Denko Forms New Biopharmaceutical CompanyBy
Nitto Denko Corporation, a manufacturer of industrial and life science products, has established a new company, Nitto BioPharma, Inc., with a focus on pharmaceutical development. Nitto has been conducting its first anti-liver fibrosis drug program (ND-L02-s0201), which is now in clinical trials in the US, Europe, and Japan, and has several other pipelines of intractable diseases in the discovery stage.
Along with the establishment of the new company, Nitto plans to set up a new facility mid-2016 in San Diego, California,
Going forward, drug discovery and development ventures, such as an anti-fibrosis and other drugs will be conducted by Nitto and the new company. By establishing this new company with a focus on pharmaceutical development, Nitto will be able to further expand its future business options and opportunities for Nitto groups.
Source: Nitto Denko